Bibliographie

Publié le 29/05/2009

Article réservé aux abonnés

1 – ANAES. Prise en charge diagnostique et traitement immédiat de l’accident ischémique transitoire de l’adulte Recommandation pour la pratique clinique Mai 2004.

2 – Woimant France. Accidents vasculaires cérébraux. RevPrat 200 ;50 :2019-2026

3 – The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-Dose Atorvastatin after Stroke or Transient Ischemic Attack. N. Engl. Journ. of Medicine. August 10, 2006 ; vol. 355 n°6 :549-558

4 – HAS. Prévention vasculaire après un infarctus cérébral ou un accident ischémique transitoire. Recommandation pour la pratique clinique. Mars 2008. http://www.has-sante.fr/portail/jcms/c_666254/prevention-vasculaire-apr…

5 – Rothwell M. Lessons from MATCH for future randomized trials in secondary prévention of stroke. Lancet 2004 ;364 :305-7

6 – Diener HC et al. Rationale, design and baseline data of randomized, double-blind, controlled trial comparing two antithrombotic regimens and telmisartan vs placebo in patients with strokes : the prevention regiment for effectively avoiding second strokes (PRoFESS) trial. Cerebrovasc 2007 ; 23 : 368-380

7- Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H et al; EVA-3S investigators. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008 Oct;7(10):885-92.

8- Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, Hennerici M, Stingele R, Fiehler J, Zeumer H, Jansen O. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008 Oct;7(10):893-902.